AbelZeta
David Lee is an experienced professional in the field of microbiology and quality control, currently serving as Senior Manager at AbelZeta since May 2024. Previous roles include Senior Manager in QC Microbiology at Emergent BioSolutions and Samsung BioLogics, Senior QC Analyst at Lonza, and Senior Microbiologist at Anika Therapeutics, among others. David Lee's expertise encompasses water sampling, bioburden testing, endotoxin testing, and comprehensive microbiological analysis, demonstrating a robust background in laboratory practices and regulatory affairs. Educational qualifications include a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor's degree in Microbiology from the University of New Hampshire.
This person is not in any offices
AbelZeta
1 followers
AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies.